Replies to post #28771 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Thanks Lunatick and Evaluate. This is helpful. Maybe Les can follow up on confirming or clarifying this. If I don't hear from management in the next day or so in a P.R. or some other form of communication (since they follow this board), I'll call them. For what that's worth.

[longusa]

Thanks Luna. Very clear from the translations of those pages that they are all PhIII sites (so there are 4 in Germany for a while now):

Chemnitz:

Neuro-Oncology

DCVax

This is a clinical Phase III trial to assess DCVax ® L, autologous dendritic cells (DC) pulsed with Tumorlysatantigen, for the treatment of glioblastoma multiforme (GMB). It is performed gGmbH in cooperation with the Department of Internal Medicine III, Klinikum Chemnitz. Important criteria for inclusion are aged between 18 and 70 years at the time of surgery and a newly diagnosed glioblastoma multiforme.

Stuttgart:

Department of Neurosurgery

Studies

The clinic currently involved in the following medical scientific studies:
• SELE I and II SELE study to evaluate the quality of life and subjective assessment of mental capacity in brain tumor patients during the first twelve months after diagnosis. Implementation of a psycho-oncological screening module in the neuro oncology clinic
• NOA-07: A multicenter pilot study on the treatment of medulloblastoma adulthood
• TMS vs. F-MRI for localization of eloquent and TMS vs. IOM in wax operations: Randomized controlled multicentre study on the influence of preoperative mapping of motor areas of the brain by means of navigated transcranial magnetic stimulation. Reliability preoperative mapping of the language region transcranial magnetic stimulation in comparison to intraoperative mapping during awake surgery.
• DC-VAX: Phase III study of immunotherapy with dendritic cells in newly diagnosed glioblastoma
• NTMs SPEECH and NTMs Engine: Nexstim studies together with Munich

Hamburg:

Dr. med. Tobias Martens
Consultant at the Department of Neurosurgery
Tel. [phone]
E-mail: [e-mail]

Consultation

Brain tumors Wednesdays 13.30 - 16.00 clock and by appointment
Epilepsy surgery Tel .: [phone]

Consultant
Specialist in Neurosurgery
Responsible for the neurooncological interdisciplinary tumor board at UKE
Expert for the certification of neuro-oncological centers by the German Cancer Society
Head of epilepsy surgery

Clinical focus
, Tumors of the brain
, Operations of tumors and lesions in eloquent areas (wax operations)
, Epilepsy surgery
, Skull Base Surgery

Publications
The current list of publications can be found at this link

Member of professional societies
, German Society of Neurosurgery (DGNC) eV
, German Cancer Society (DKG) eV
, Neuro-Oncology Working Group in the DKG (NOA)
, German Society for epileptology (DGfE) eV
, Association for presurgical diagnostics and operational
Epilepsy Therapy Association

Investigator of clinical trials

CONSCIOUS-2 / Actelion, Phase III
CONSCIOUS-3 / Actelion, Phase III
SAPPHIRE / Isarna, Phase III
OSAG101 / Oncoscience, Phase III
CENTRIC / Merck, Phase III
AVAGLIO / Roche, Phase III
APG101 / APOGENIX, Phase II (principal investigator)
EF-11 / Novocure, Phase III
EF-14 / Novocure, Phase III
Jbal / Lilly, Phase II
MetMAb / Roche, Phase II
ACT IV / Celldex, Phase III
DCVax / Northwest, Phase III
Bracco / Ecron